Berbegall, Ana P.
Bogen, Dominik
Pötschger, Ulrike
Beiske, Klaus
Bown, Nick
Combaret, Valérie
Defferrari, Raffaella
Jeison, Marta
Mazzocco, Katia
Varesio, Luigi
Vicha, Ales
Ash, Shifra
Castel, Victoria
Coze, Carole
Ladenstein, Ruth
Owens, Cormac
Papadakis, Vassilios
Ruud, Ellen
Amann, Gabriele
Sementa, Angela R.
Navarro, Samuel
Ambros, Peter F.
Noguera, Rosa
Ambros, Inge M.
Article History
Received: 28 July 2017
Revised: 1 March 2018
Accepted: 6 April 2018
First Online: 14 May 2018
Ethics approval and consent to participate
: The institutional ethics board of each hospital and institutions approved the use of neuroblastoma samples and/or clinical data of patients registered in SIOPEN protocols and databases: Regional Committees for Medical and Health Research Ethics; “Comité de Protection des Personnes Sud-Est IV”, references L07–95/L12–171; Ethics Committee for Multi-Centric Trials of the University Hospital Motol; Rabin Medical Center Helsinki Committee; COMITE DE PROTECTION DES PERSONNES SUD MEDITERRANEE II; Ethikkommission der Medizinischen Universität Wien, Austria; National Health System, 1st Health Administration - Periphery of Attica; General Children’s Hospital “Agia Sophia”; and “Comité de Protection des Personnes Ile de France”, reference 0811728. Parents or guardians of patients aged <18 years and adult patients (≥18 years) provided written informed consent.
: The authors declare no competing interests.